JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
MACOM Technology Solutions
MTSI
$23.5B
| $348K | ﹤0.01% |
23,650
-92
| -0.4% | -$1.39K |
|
4227
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.88B
| $348K | ﹤0.01% |
5,253
+209
| +4% | +$13.6K |
|
|
NBIS
4228
PUT
Nebius Group N.V.
NBIS
$69.3B
| $346K | ﹤0.01% |
+8,900
| New | +$330K |
|
4229
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.23B
| $345K | ﹤0.01% |
5,734
-1,008
| -15% | -$60.6K |
|
4230
Navigator Holdings
NVGS
$1.26B
| $344K | ﹤0.01% |
37,583
-4,506
| -11% | -$47.1K |
|
4231
Invesco Financial Preferred ETF
PGF
$669M
| $344K | ﹤0.01% |
18,687
-547
| -3% | -$10.1K |
|
4232
Travere Therapeutics
TVTX
$5.79B
| $344K | ﹤0.01% |
17,172
+2,815
| +20% | +$55.6K |
|
4233
Spyre Therapeutics
SYRE
$8.98B
| $343K | ﹤0.01% |
2,138
+1,871
| +701% | +$323K |
|
4234
PUT
Best Buy
BBY
$18B
| $342K | ﹤0.01% |
5,000
-768,000
| -99% | -$53.6M |
|
4235
Accuray
ARAY
$32.9M
| $341K | ﹤0.01% |
87,749
-465,446
| -84% | -$1.88M |
|
|
EIGR
4236
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $340K | ﹤0.01% |
1,059
-581
| -35% | -$201K |
|
|
ATXS
4237
DELISTED
Astria Therapeutics
ATXS
| $339K | ﹤0.01% |
7,234
+5,517
| +321% | +$250K |
|
4238
Veracyte
VCYT
$3.59B
| $339K | ﹤0.01% |
12,796
+5,893
| +85% | +$147K |
|
4239
INNOVATE Corp
VATE
$105M
| $338K | ﹤0.01% |
13,797
-138,340
| -91% | -$3.4M |
|
4240
Heartland Express
HTLD
$950M
| $337K | ﹤0.01% |
18,547
-78,502
| -81% | -$1.5M |
|
4241
iRadimed
IRMD
$1.11B
| $337K | ﹤0.01% |
16,796
-20,326
| -55% | -$479K |
|
4242
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$479M
| $337K | ﹤0.01% |
5,105
| – | – |
|
|
AERI
4243
DELISTED
Aerie Pharmaceuticals
AERI
| $337K | ﹤0.01% |
11,595
+2,953
| +34% | +$114K |
|
4244
KLX Energy Services
KLXE
$35.1M
| $336K | ﹤0.01% |
3,403
+17
| +0.5% | +$2.06K |
|
|
IBMJ
4245
DELISTED
iShares iBonds Dec 2021 Term Muni Bond ETF
IBMJ
| $335K | ﹤0.01% |
13,014
| – | – |
|
4246
Marcus & Millichap
MMI
$1.18B
| $333K | ﹤0.01% |
10,888
+6,143
| +129% | +$223K |
|
4247
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $333K | ﹤0.01% |
15,405
-382,105
| -96% | -$8.13M |
|
4248
Texas Pacific Land
TPL
$23.6B
| $333K | ﹤0.01% |
3,825
-585
| -13% | -$52.5K |
|
|
OPB
4249
DELISTED
Opus Bank Common Stock
OPB
| $333K | ﹤0.01% |
15,713
+103
| +0.7% | +$2.17K |
|
4250
Xenon Pharmaceuticals
XENE
$6.31B
| $332K | ﹤0.01% |
33,594
-62,810
| -65% | -$601K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.